Chiropractors in Destrehan, LA Accepting Medicare

3 Chiropractors found. Showing 1 - 3

Melissa Marie Arceneaux-myers, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1950 Ormond Blvd Ste A, Destrehan, LA 70047 Phone: 985-764-4004    Fax: 985-725-3300

Dr. Adam Wayne Roussel, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1972 Ormond Blvd Ste A, Destrehan, LA 70047 Phone: 985-307-0977    Fax: 859-307-0984

Chiropractic Total Wellness Center, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1950 Ormond Blvd Ste A, Destrehan, LA 70047 Phone: 985-764-4004    Fax: 985-725-3300

News Archive

Views on Medicare feud: Both sides working toward cuts; If vouchers aren't the answer, what is?

Americans who don't count themselves confused by the current debate over Medicare must be in the minority. Mitt Romney and Republican running mate Rep. Paul D. Ryan accused President Obama of hurting seniors by cutting $716 billion from the federal health program. The president retorts that the Republicans would "end Medicare as we know it." The truth is that both sides have plans that dramatically change the nearly half-century-old program.

SCRI to lead clinical development of AstraZeneca's novel targeted oncology compound

AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.

Capecitabine increases disease-free survival for HER2-negative breast cancer patients

Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results from the phase III CREATE-X clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.

Dendreon requests licensure for additional capacity to manufacture PROVENGE at New Jersey facility

Dendreon Corporation today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility. Dendreon is requesting licensure for an additional 36 workstations to manufacture PROVENGE. The standard U.S. Food and Drug Administration (FDA) review for a post-approval supplement to a Biologics License Application is typically four months.

Homeless heart attack patients receive less treatment and are more likely to be readmitted

Homelessness has become a social crisis and public health problem around the world, affecting people of all ages. Most homeless people are at a disadvantage with few resources, and may or may not have adequate health insurance.

Read more Medical News

› Verified 6 days ago